Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Positron-Emission Tomography. Found 15 abstracts

Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller S, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cavalli F, Lister TA, Cheson BD. Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al [Letter]. J Clin Oncol. 2015 Apr;33(10):1221-3.
Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller S, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cavalli F, Lister TA, Cheson BD. Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al. J Clin Oncol. 2015 Apr;33(10):1221-3.
Carlier T, Willowson KP, Fourkal E, Bailey DL, Doss M, Conti M. (90)Y -PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fraction. Med Phys. 2015 Jul;42(7):4295-309.
Marks EI, Tan C, Zhang J, Zhou L, Yang Z, Scicchitano A, El-Deiry WS. Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy. Cancer Biol Ther. 2015 Jan;16(12):1710-9.   PMCID: PMC4847811
Willowson KP, Tapner M, The QI, Bailey DL, Willowson KP, Tapner MJ, Ahmadzadehfar H, Amthauer H, Großer OS, Arbizu J, Martí-Climent JM, Rodriguez-Fraile M, Attarwala AA, Glatting G, Molina-Duran F, Bagni O, Filippi L, Benard F, Celler A, Bonutti F, Botta F, Ferrari M, Boucek JA, Francis R, Bourgeois AC, Bradley YC, Pasciak AS, Buchholz HG, Miederer M, Büsing KA, Schönberg SO, Carlier T, Eugene T, Cervo M, Moore SC, Civollani S, Pettinato C, Conti M, Craig AJ, Flux GD, Cremonesi M, D’Andrea M, Iaccarino G, Strigari L, D’Arienzo M, D’Asseler Y, Lambert B, Di Martino F, Doss M, Duan H, Hoffmann M, Flamen P, Vanderlinden B, Fletcher AM, Fourkal E, Freeman LM, Geatti O, Goedicke A, Habito CM, Ouyang J, Hallam A, Morgan DG, Heard S, Leek F, Holm S, Mortensen J, de Nijs R, Hooker CA, Jeans SP, Julyan PJ, Kabasakal L, Tanyildizi H, Tanyildizi H, Kappadath SC, Siman W, Lassmann M, Schlögl S, Law MW, Lee VH, Ng SC, Lhommel R, Lodge MA, Luster M, McGowan DR, McLamb B, Kaiser HJ, Mottaghy FM, Mulder RU, Judy P, Stone JR, Lopez A, Munk OL, Staanum PF, Muzaffar R, Osman MM, Nijran KS, Towey DJ, O’Keefe GJ, Pooley RA, McKinney JM, Rausch IF, Reindl M, Sheikh A, Song N, Srinivas SM, Weir G, Yu N, Bailey DL. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study. European Journal of Nuclear Medicine and Molecular Imaging. 2015 Jul;42(8):1202-22.   PMCID: 4480824
Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cheson BD. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology. 2014 Sep;32(27):3048-58.   PMCID: 5015423
Doss M, Kolb HC, Walsh JC, Mocharla VP, Zhu Z, Haka M, Alpaugh RK, Chen DY, Yu JQ. Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteers. Mol Imaging Biol. 2014 Oct;16(5):739-46.
Tokar JL, Walia R. Diagnostic evaluation of solid pancreatic masses. Current gastroenterology reports. 2013 Oct;15(10):347.
Klayton T, Li T, Yu JQ, Keller L, Cheng J, Cohen SJ, Meropol NJ, Scott W, Xu-Welliver M, Konski A. The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma. J Gastrointest Cancer. 2012 Dec;43(4):612-8.
Fourkal E, Fan J, Veltchev I. Absolute dose reconstruction in proton therapy using PET imaging modality: feasibility study. Phys Med Biol. 2009 Jun 07;54(11):N217-28.
Konski A, Li T, Sigurdson E, Cohen SJ, Small W, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys. 2009 May;74(1):55-9.   PMCID: PMC2933375
Podoloff DA, Ball DW, Ben-Josef E, Benson AB, Cohen SJ, Coleman RE, Delbeke D, Ho M, Ilson DH, Kalemkerian GP, Lee RJ, Loeffler JS, Macapinlac HA, Morgan RJ, Siegel BA, Singhal S, Tyler DS, Wong RJ. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw. 2009 Jun;7 Suppl 2:S1-26.
Kell MR, Ridge JA, Joseph N, Sigurdson ER. PET CT imaging in patients undergoing sentinel node biopsy for melanoma. Eur J Surg Oncol. 2007 Sep;33(7):911-3.
Konski AA, Cheng JD, Goldberg M, Li T, Maurer A, Yu JQ, Haluszka O, Scott W, Meropol NJ, Cohen SJ, Freedman G, Weiner LM. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2007 Oct;69(2):358-63.
Dell DD. Spread the word about breast cancer. Nursing. 2005 Oct;35(10):56-63; quiz 63-4.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Positron-Emission Tomography

Positron-Emission Tomography Radiopharmaceuticals radionuclide imaging Fluorodeoxyglucose F18 X-Ray Computed Tomography methods therapy Neoplasm Staging diagnostic use pathology Female therapeutic use Middle Aged Male Adenocarcinoma Prognosis Imaging Phantoms Lymphoma Treatment Outcome Antineoplastic Combined Chemotherapy Protocols metabolism Differential Diagnosis pharmacokinetics Aged drug therapy Lymph Node Excision Magnetic Resonance Imaging Yttrium Radioisotopes Analysis of Variance Combined Modality Therapy Radiation Dosage Radiotherapy Dosage Algorithms Fluorouracil Predictive Value of Tests Esophageal Neoplasms diagnosis Squamous Cell Carcinoma Multimodal Imaging Adult Biopsy Healthy Volunteers Tumor Cell Line Risk Factors Radiometry Follow-Up Studies Esophagectomy et [Etiology] Sentinel Lymph Node Biopsy Pyridines Prospective Studies Computer Simulation International Cooperation Endoscopic Ultrasound-Guided Fine Needle Aspiration Three-Dimensional Imaging di [Diagnosis] analogs & Neoplasm Metastasis Feasibility Studies classification Melanoma Rectal Neoplasms Breast Neoplasms th [Therapy] Neoplasms Monte Carlo Method X-Ray Microtomography metastatic colorectal adenocarcinoma utilization Neoadjuvant Therapy Nurse's Role adverse effects Sulfonamides Lymph Nodes Retrospective Studies Lymphatic Metastasis Microspheres Phenylurea Compounds Colorectal Neoplasms Pyrimidines Chemoradiotherapy Patient Education Neoplasm Antigens Carbonic Anhydrases Protons derivatives Retreatment Mammaplasty Disease-Free Survival chemical synthesis 5-fu Pancreatic Diseases mt [Methods] regorafenib Mitomycin Mammography instrumentation radiotherapy Mass Screening surgery administration & Mastectomy Theoretical Models Dipeptides Nonparametric Statistics administration & dosage chemistry capecitabine mortality Tissue Distribution Risk Assessment Deoxycytidine Endosonography Photons Therapeutic Embolization Emission-Computed Tomography Pancreatic Neoplasms Tumor Biomarkers dosage Water
Last updated on Wednesday, February 05, 2020